# Adherence to HIV Therapy in Heroin Addicts: Oral vs XR-NTX

> **NCT01101815** · PHASE2 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 200 (actual)

## Conditions studied

- HIV
- Substance Abuse
- HIV Infections

## Interventions

- **DRUG:** Oral Naltrexone
- **DRUG:** Naltrexone Implant
- **BEHAVIORAL:** Group Drug Counseling Manual Driven

## Key facts

- **NCT ID:** NCT01101815
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2018-11-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01101815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01101815, "Adherence to HIV Therapy in Heroin Addicts: Oral vs XR-NTX". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01101815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*